Abstract: The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in inducing neuroprotection, in a subject in need thereof. The compound or a pharmaceutically acceptable salt thereof can be used in inducing neuroprotection in a subject suffering from, suspected of suffering from, or considered to be at risk of suffering from a neurodegenerative pathology. The compound or a pharmaceutically acceptable salt thereof also can be used in preventing or treating a neurodegenerative pathology, and/or in preventing or decreasing cognitive impairment in a subject suffering from, suspected of suffering from, or considered to be at risk of suffering from a neurodegenerative pathology.

Abstract: The present invention relates to fluoroethylnormemantine or one of the salts thereof for the treatment of anxiety and, more particularly, post-traumatic stress conditions, either alone or in combination with chemical antidepressant treatments or cognitive and behavioral techniques.

Abstract: The present invention relates to fluoroethylnormemantine or one of the salts thereof for the treatment of anxiety and, more particularly, post-traumatic stress conditions, either alone or in combination with chemical antidepressant treatments or cognitive and behavioral techniques.

Abstract: A method for compacting powdery compositions wherein the composition is compacted down to a reduced volume and the composition is then maintained at constant volume until the solid compact product is obtained.

Abstract: The present invention relates to tablets allowing hot drinks to be prepared by lixiviation and especially coffee. It also relates to the preparation method by which said tablets may be made.

Abstract: The present invention relates to a compacted solid product for water purification comprising:—at least a first layer comprising at least a coagulant/flocculant system comprising at least one polyvalent inorganic salt, at least one water-soluble cationic polymer and at least one high-molecular-weight anionic polymer,—at least a second layer comprising at least one disinfectant that releases active chlorine on contact with water, characterized in that said coagulant/flocculant system moreover comprises a sodium alginate. The invention also relates to the method for preparing such a product.

Abstract: The invention relates to new non-therapeutic methods allowing the level of skin neurosensitivity and/or the state of neurosensorial skin reactivity of an individual to be evaluated by applying a peripheral nervous system stimulant to one skin area, the method being implemented under conditions of safety and comfort acceptable for the user, irrespective of his or her skin type.

Abstract: The present invention relates to tablets allowing hot drinks to be prepared by lixiviation and especially coffee. It also relates to the preparation method by which said tablets may be made.

Abstract: A method for compacting powdery compositions wherein the composition is compacted down to a reduced volume and the composition is then maintained at constant volume until the solid compact product is obtained.

Abstract: The present invention relates to a compacted solid product for water purification comprising:—at least a first layer comprising at least a coagulant/flocculant system comprising at least one polyvalent inorganic salt, at least one water-soluble cationic polymer and at least one high-molecular-weight anionic polymer,—at least a second layer comprising at least one disinfectant that releases active chlorine on contact with water, characterized in that said coagulant/flocculant system moreover comprises a sodium alginate. The invention also relates to the method for preparing such a product.

Abstract: Disclosed methods and systems related to enabling an analysis using a three-dimensional facial image. One of the methods involves facilitating construction of a three-dimensional facial image using at least captured image of a subject's face. The method also involves facilitating a simulation of use of an aesthetic feature on the three-dimensional facial image and/or processing of the three-dimensional facial image to enable a beauty analysis.

Abstract: The invention relates to a detergent tablet characterized in that it comprises five layers superimposed on each other, with at least three layers among the five layers having different compositions. The invention also relates to a method for manufacturing such a detergent tablet.

Abstract: A method of performing a beauty analysis is disclosed. The method comprises receiving information of at least one portion of a subject's external body condition, identifying in the information at least one condition, extracting from the information at least one feature of the at least one condition, and storing extracted information reflective of the at least one feature.

Abstract: The present invention relates to a method for the cosmetic treatment of dry skin or of a dry scalp, comprising the topical application to the skin or the scalp of a composition containing, in a physiologically acceptable medium, at least one alkyl ether of hydroxystilbene with a saturated or unsaturated, linear or branched C1-C6 alcohol. The composition may be used for cosmetic purposes, for treating drying out of the skin, in particular after the menopause, or for dermatological purposes, for treating disorders associated with oligoseborrhoeic dry skin, in particular forms of dermatitis.

Abstract: The present invention relates to the use of at least one amide, a mono- or polyester of suger and of fatty acid, especially linoleic acid, for the preparation of a cosmetic of pharmaceutical composition intented for treating and/or preventing dry skin. It also relates to the use of at least one amide, a sugar mono- or polyester of fatty acid, for the preparation of a cosmetic composition intented for treating oligoseborrhoeic dry skin and/or for stimulating sebum production. It also relates to the use of at least one amide, a mono- or polyester of sugar of linoleic acid for the preparation of a cosmetic or pharmaceutical composition, intented for generating 13-hydroxy-octadecadienoic acid and/or for treating and/or preventing skin disorders and/or disorders of the pilosebaceous unit associated with a deficit of linoleic acid.

Abstract: The present invention relates to the use of a sapogenin, chosen from diosgenin and hecogenin, and/or of a plant extract containing at least one of these sapogenins. A preferred use is the treatment of oligoseborrheic dry skin. Another preferred use is the treatment of dry scalp. Compositions containing these sapogenins are also described.

Abstract: The invention relates to: a cosmetic composition that mimics sebum; a preparation method thereof; the use of same in cosmetics; the use of same for the preparation of a skin equivalent comprising a sebum equivalent; a skin equivalent comprising a sebum equivalent; and the use of a skin equivalent comprising a sebum equivalent.

Abstract: The present invention includes a method for predicting evolution of at least one condition of an external body portion of a subject. The method may include receiving first data, receiving second data, generating a forecasted or expected evolution of the at least one condition of the external body portion of the subject based on the first data and the second data, and transmitting to the subject the forecasted evolution. The first data may be representative of at least one condition of the external body portion of the subject in a first time frame. The second data may be representative of the at least one condition of the external body portion of the subject in a second time frame occurring after the first time frame. A beauty product may be applied to the external body portion between the first and second time frames.

Abstract: The invention relates to new non-therapeutic methods allowing the level of skin neurosensitivity and/or the state of neurosensorial skin reactivity of an individual to be evaluated by applying a peripheral nervous system stimulant to one skin area, the method being implemented under conditions of safety and comfort acceptable for the user, irrespective of his or her skin type.

Abstract: The present invention relates to the use of a sapogenin, chosen from diosgenin and hecogenin, and/or of a plant extract containing at least one of these sapogenins. A preferred use is the treatment of oligoseborrheic dry skin. Another preferred use is the treatment of dry scalp. Compositions containing these sapogenins are also described.